UTAH MEDICAL PRODUCTS, INC. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $50.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-14.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2019-03-14
- UTAH MEDICAL PRODUCTS, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2016 was $50.00K, a 56.14% decline from fiscal 2015.
- UTAH MEDICAL PRODUCTS, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2015 was $114.00K, a 10.68% increase from fiscal 2014.
- UTAH MEDICAL PRODUCTS, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2014 was $103.00K, a 63.35% decline from fiscal 2013.
- UTAH MEDICAL PRODUCTS, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2013 was $281.00K, a 57.87% increase from fiscal 2012.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month |
|---|---|
| 2016-12-31 | $50.00K 10-K · filed 2019-03-14 |
| 2015-12-31 | $114.00K 10-K · filed 2018-03-06 |
| 2014-12-31 | $103.00K 10-K · filed 2017-03-08 |
| 2013-12-31 | $281.00K 10-K · filed 2016-03-10 |
| 2012-12-31 | $178.00K 10-K · filed 2015-03-12 |
| 2011-12-31 | $34.00K 10-K · filed 2014-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |